美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

LB Pharmaceuticals Inc

48.62

+0.40500.84%

成交量：15.03萬

成交額：737.50萬

市值：15.68億

市盈率：-16.27

高：50.16

開：48.70

低：48.50

收：48.21

52周最高：50.16

52周最低：13.36

股本：3,225.92萬

流通股本：2,162.18萬

量比：0.63

換手率：0.69%

股息：- -

股息率：- -

每股收益(TTM):-2.9880

每股收益(LYR):-3.1329

淨資產收益率：-50.00%

總資產收益率：-29.98%

市淨率：4.72

市盈率(LYR):-15.52

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

美國研究綜述-卡迪納爾健康、盧門圖姆控股、公共倉儲

LB Pharmaceuticals 雙相抑鬱症II期Illuminate-1試驗頂線數據預計於2028年第一季度公布

LB製藥宣佈Lb-102精神分裂症三期Nova-2試驗頂線結果加速揭曉

新聞稿：LB Pharmaceuticals 根據納斯達克上市規則 5635(c)(4) 向新員工授予激勵性股權獎勵

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/LBRX"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"LBRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LBRX\",,,,,undefined,":{"symbol":"LBRX","market":"US","secType":"STK","nameCN":"LB Pharmaceuticals Inc","latestPrice":48.615,"timestamp":1787684881925,"preClose":48.21,"halted":0,"volume":150262,"delay":0,"changeRate":0.00840074673304296,"floatShares":21621800,"shares":32259175,"eps":-2.988,"marketStatus":"交易中","change":0.405,"latestTime":"08-25 15:08:14 EDT","open":48.7,"high":50.16,"low":48.5,"amount":7374976.16436,"amplitude":0.034433,"askPrice":48.74,"askSize":88,"bidPrice":48.52,"bidSize":4,"shortable":3,"etf":0,"ttmEps":-2.988,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1787688000000},"marketStatusCode":2,"adr":0,"listingDate":1757563200000,"exchange":"NASDAQ","adjPreClose":48.21,"preHourTrading":{"tag":"盘前","latestPrice":49.99,"preClose":48.21,"latestTime":"09:04 EDT","volume":7,"amount":343.49,"timestamp":1787663087050,"change":1.78,"changeRate":0.036922,"amplitude":0.030906},"postHourTrading":{"tag":"盘后","latestPrice":48.21,"preClose":48.21,"latestTime":"19:30 EDT","volume":1229,"amount":59262.11,"timestamp":1787614207179,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.628299,"impliedVol":0.6752,"impliedVolPercentile":0.4754},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LBRX\",,,,,undefined,":{"symbol":"LBRX","floatShares":21621800,"roa":"-29.98%","roe":"-50.00%","lyrEps":-3.132945,"volumeRatio":0.628299,"shares":32259175,"dividePrice":0,"high":50.16,"amplitude":0.034433,"preClose":48.21,"low":48.5,"week52Low":13.36,"pbRate":"4.72","week52High":50.16,"institutionHeld":0,"latestPrice":48.615,"committee":-0.913043,"eps":-2.988,"divideRate":0,"volume":150262,"delay":0,"ttmEps":-2.988,"open":48.7,"prevYearClose":22.26,"prevWeekClose":47.62,"prevMonthClose":40.08,"prevQuarterClose":32.455,"fiveDayClose":48.77,"twentyDayClose":34.94,"sixtyDayClose":27.97},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LBRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"LBRX","fiscalQuarterEnding":"2026/06","expectedEps":-0.84,"name":null,"time":"盤前","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"pre","actualEps":-1.71},{"market":"US","date":"2026-05-12","symbol":"LBRX","fiscalQuarterEnding":"2026/03","expectedEps":-0.75,"name":null,"time":"盤後","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"post","actualEps":-0.67},{"market":"US","date":"2026-03-26","symbol":"LBRX","fiscalQuarterEnding":"2025/12","expectedEps":-0.45,"name":null,"time":"盤後","type":"earning","dateTimestamp":1774497600000,"reportTimeType":"post","actualEps":-0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LBRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LBRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1784779200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LBRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LBRX","date":"2026-08-24","current":-16.27008,"percent":0.797468,"low":-37.407457,"twenty":-31.993865,"median":-24.857779,"eighty":-17.84015,"high":-0.410019,"avg":-24.312143,"sd":7.577604,"marketCap":1536181913},"quantilePoints":[{"date":"2025-09-12","current":-13.187639,"twenty":-10.632115,"median":-6.798829,"eighty":-2.965543,"marketCap":388099031},{"date":"2025-09-19","current":-12.217088,"twenty":-12.798201,"median":-12.438246,"eighty":-12.070666,"marketCap":359536683},{"date":"2025-09-26","current":-11.40109,"twenty":-12.682283,"median":-12.163705,"eighty":-11.408716,"marketCap":335522685},{"date":"2025-10-03","current":-11.790024,"twenty":-12.394014,"median":-12.03406,"eighty":-11.475827,"marketCap":346968609},{"date":"2025-10-10","current":-11.927294,"twenty":-12.217088,"median":-11.973051,"eighty":-11.471251,"marketCap":351008347},{"date":"2025-10-17","current":-12.506882,"twenty":-12.401641,"median":-12.018808,"eighty":-11.491079,"marketCap":368065019},{"date":"2025-10-24","current":-12.079817,"twenty":-12.247593,"median":-12.026434,"eighty":-11.561239,"marketCap":355496945},{"date":"2025-10-31","current":-12.415368,"twenty":-12.43367,"median":-12.041687,"eighty":-11.652753,"marketCap":365371860},{"date":"2025-11-07","current":-18.511527,"twenty":-12.493155,"median":-12.14464,"eighty":-11.774771,"marketCap":348090759},{"date":"2025-11-14","current":-20.046619,"twenty":-12.715838,"median":-12.201836,"eighty":-11.777822,"marketCap":376956619},{"date":"2025-11-21","current":-21.244034,"twenty":-16.587413,"median":-12.217088,"eighty":-11.811377,"marketCap":399472820},{"date":"2025-11-28","current":-23.934856,"twenty":-18.511527,"median":-12.278098,"eighty":-11.89679,"marketCap":450071024},{"date":"2025-12-05","current":-25.899155,"twenty":-20.625145,"median":-12.354359,"eighty":-11.912042,"marketCap":487007713},{"date":"2025-12-12","current":-27.217658,"twenty":-21.714928,"median":-12.472564,"eighty":-11.927294,"marketCap":511800833},{"date":"2025-12-19","current":-26.50459,"twenty":-23.934856,"median":-12.598395,"eighty":-11.934921,"marketCap":498392309},{"date":"2025-12-26","current":-29.599034,"twenty":-25.317938,"median":-12.735666,"eighty":-11.971526,"marketCap":556580244},{"date":"2026-01-02","current":-29.948841,"twenty":-26.033696,"median":-12.811928,"eighty":-12.003556,"marketCap":563158010},{"date":"2026-01-09","current":-27.984542,"twenty":-26.736001,"median":-17.717835,"eighty":-12.027959,"marketCap":526221321},{"date":"2026-01-16","current":-28.76488,"twenty":-26.943194,"median":-18.511527,"eighty":-12.038636,"marketCap":540894800},{"date":"2026-01-23","current":-31.724783,"twenty":-27.597063,"median":-20.046619,"eighty":-12.056939,"marketCap":596552825},{"date":"2026-01-30","current":-28.482344,"twenty":-28.30475,"median":-20.93459,"eighty":-12.092019,"marketCap":535581989},{"date":"2026-02-06","current":-32.101498,"twenty":-28.673392,"median":-21.418938,"eighty":-12.137776,"marketCap":603636573},{"date":"2026-02-13","current":-32.760749,"twenty":-28.899421,"median":-22.367452,"eighty":-12.188109,"marketCap":616033133},{"date":"2026-02-20","current":-32.558938,"twenty":-29.179266,"median":-23.692682,"eighty":-12.201836,"marketCap":612238268},{"date":"2026-02-27","current":-32.5993,"twenty":-29.599034,"median":-24.876643,"eighty":-12.203361,"marketCap":612997241},{"date":"2026-03-06","current":-31.684421,"twenty":-30.30403,"median":-25.616619,"eighty":-12.210987,"marketCap":595793852},{"date":"2026-03-13","current":-33.554542,"twenty":-31.627914,"median":-25.899155,"eighty":-12.217088,"marketCap":630959603},{"date":"2026-03-20","current":-32.276402,"twenty":-31.988483,"median":-26.370049,"eighty":-12.224714,"marketCap":606925456},{"date":"2026-03-27","current":-24.621582,"twenty":-31.988483,"median":-26.625677,"eighty":-12.26437,"marketCap":620586972},{"date":"2026-04-02","current":-24.902627,"twenty":-31.966957,"median":-26.235508,"eighty":-12.300976,"marketCap":627670720},{"date":"2026-04-10","current":-26.388153,"twenty":-31.886233,"median":-26.156251,"eighty":-12.33148,"marketCap":665113391},{"date":"2026-04-17","current":-28.385582,"twenty":-31.84587,"median":-26.235508,"eighty":-12.354359,"marketCap":715458604},{"date":"2026-04-24","current":-35.011617,"twenty":-31.993865,"median":-26.565134,"eighty":-12.415368,"marketCap":882467800},{"date":"2026-05-01","current":-36.076352,"twenty":-32.168769,"median":-26.669198,"eighty":-12.438246,"marketCap":909304449},{"date":"2026-05-08","current":-36.38353,"twenty":-32.30331,"median":-26.814034,"eighty":-12.506882,"marketCap":917046871},{"date":"2026-05-15","current":-23.123601,"twenty":-32.316764,"median":-26.760218,"eighty":-12.583143,"marketCap":900733639},{"date":"2026-05-22","current":-20.613207,"twenty":-32.30331,"median":-26.667619,"eighty":-12.598395,"marketCap":802946256},{"date":"2026-05-29","current":-20.2672,"twenty":-32.30331,"median":-26.565134,"eighty":-12.6289,"marketCap":789468229},{"date":"2026-06-05","current":-21.275774,"twenty":-32.281784,"median":-26.235508,"eighty":-12.715838,"marketCap":828755242},{"date":"2026-06-12","current":-21.010748,"twenty":-32.254875,"median":-25.973152,"eighty":-12.741767,"marketCap":818431648},{"date":"2026-06-18","current":-22.122388,"twenty":-32.201059,"median":-25.758446,"eighty":-12.784474,"marketCap":861733392},{"date":"2026-06-26","current":-22.821765,"twenty":-32.168769,"median":-25.603165,"eighty":-13.037355,"marketCap":888976212},{"date":"2026-07-02","current":-23.476971,"twenty":-32.141861,"median":-25.394457,"eighty":-14.887526,"marketCap":914498432},{"date":"2026-07-10","current":-24.838915,"twenty":-32.079972,"median":-25.197689,"eighty":-17.661739,"marketCap":967550238},{"date":"2026-07-17","current":-22.519929,"twenty":-32.026155,"median":-24.876643,"eighty":-18.127213,"marketCap":877218784},{"date":"2026-07-24","current":-25.486758,"twenty":-31.993865,"median":-24.857779,"eighty":-18.396949,"marketCap":992785692},{"date":"2026-07-31","current":-30.110006,"twenty":-31.988483,"median":-25.029051,"eighty":-18.623718,"marketCap":1172875066},{"date":"2026-08-07","current":-35.46944,"twenty":-32.036919,"median":-25.243817,"eighty":-19.236335,"marketCap":1381641093},{"date":"2026-08-14","current":-16.667021,"twenty":-32.036919,"median":-25.197689,"eighty":-18.062763,"marketCap":1428113677},{"date":"2026-08-21","current":-17.781418,"twenty":-31.993865,"median":-24.876643,"eighty":-17.822455,"marketCap":1523600835},{"date":"2026-08-24","current":-17.928248,"twenty":-31.993865,"median":-24.857779,"eighty":-17.84015,"marketCap":1536181913}],"updateTime":1787684894445},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LBRX\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658927621","title":"美國研究綜述-卡迪納爾健康、盧門圖姆控股、公共倉儲","url":"https://stock-news.laohu8.com/highlight/detail?id=2658927621","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658927621?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 16:08","pubTimestamp":1786522123,"startTime":"0","endTime":"0","summary":"美国研究综述-卡迪纳尔健康、卢门图姆控股、公共仓储路透8月12日-周三，华尔街证券分析师调整了多家在美国上市公司的评级和目标股价，其中包括卡迪纳尔健康、卢门图姆控股和公共仓储。股票按字母顺序排列。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL4S4490GS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FLUT","VTR","MAA","RPD","LBRX","MIDD","UMAC","AMBQ","CUBE","LOW","MRCY","URBN","LPTH","NTRA","JAZZ","CANC","EXR","LENZ","SR","BCAX","BBIO","NEMG","CRWV","CRCL","ANF","EGGY","LITE","CVS","MNST","PSA","TXG","LEGN","MDLN","NEM","ACVA","REIT","WELL","HLIO","SGMT","TGT","HD","CAVA","GAP","COAG","PNW","USFD","JBIO","ACM","BLCK","CAH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151715449","title":"LB Pharmaceuticals 雙相抑鬱症II期Illuminate-1試驗頂線數據預計於2028年第一季度公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1151715449","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151715449?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 20:04","pubTimestamp":1784721854,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals Inc 宣布，其针对双相抑郁症的II期临床试验Illuminate-1的顶线数据，预计将在2028年第一季度获得。这一关键时间点的披露，将有助于市场评估该药物候选品的临床潜力与未来开发前景。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112760623","title":"LB製藥宣佈Lb-102精神分裂症三期Nova-2試驗頂線結果加速揭曉","url":"https://stock-news.laohu8.com/highlight/detail?id=1112760623","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112760623?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 20:02","pubTimestamp":1784721757,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals Inc  宣布，其针对精神分裂症的在研药物Lb-102，其关键性三期临床试验的顶线结果揭晓时间将比原计划提前。Nova-2试验是评估Lb-102疗效与安全性的关键一步，其结果将直接影响该药物的未来审批前景与商业潜力。公司此次主动调整时间表，通常被市场解读为对试验进展持有信心的信号。对于深耕中枢神经系统疾病领域的LB Pharmaceuticals而言，Lb-102是其研发管线中的重要资产，此次试验的加速推进无疑将吸引更多目光聚焦于公司的后续发展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LBRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114125454","title":"新聞稿：LB Pharmaceuticals 根據納斯達克上市規則 5635(c)(4) 向新員工授予激勵性股權獎勵","url":"https://stock-news.laohu8.com/highlight/detail?id=1114125454","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114125454?lang=zh_tw&edition=fundamental","pubTime":"2026-07-11 04:44","pubTimestamp":1783716299,"startTime":"0","endTime":"0","summary":"2026年7月10日，LB Pharmaceuticals Inc宣布，已根据纳斯达克上市规则5635的“激励性授予”例外条款，向新任临床运营高级副总裁Christopher Zergebel授予了一项股权奖励。该奖励旨在作为Zergebel先生加入公司任职的重要激励。此次授予的股权奖励虽在LB Pharmaceuticals Inc 2025年股权激励计划之外进行，但仍受其条款与条件约束。Zergebel先生获得了一项购买75,000股LB Pharmaceuticals普通股的期权。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QQQE",".IXIC","BK4007","JEPQ","QQQA","LBRX","NQmain","NDX","BK4213","MNQmain","GPIQ","QLD","QQQJ","QQQ","NVIW.SI","QQQY","SQQQ","LB","QQQM","QID","ONEQ","PSQ","BK4233","TQQQ","QYLG","QDTE","TQQY","FTEC","IYW","TECS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/LBRX\",params:#limit:6,delay:false,,,undefined,":[]}}